Display options
Share it on

J Hepatol. 2015 May;62(5):1204-6. doi: 10.1016/j.jhep.2014.12.025. Epub 2015 Jan 02.

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.

Journal of hepatology

Tarek Hassanein, Karen D Sims, Michael Bennett, Norman Gitlin, Eric Lawitz, Tuan Nguyen, Lynn Webster, Zobair Younossi, Howard Schwartz, Paul J Thuluvath, Helen Zhou, Bhaskar Rege, Fiona McPhee, Nannan Zhou, Megan Wind-Rotolo, Ellen Chung, Amber Griffies, Dennis M Grasela, David F Gardiner

Affiliations

  1. Southern California Liver Centers, Coronado, CA, USA. Electronic address: [email protected].
  2. Bristol-Myers Squibb, Hopewell, NJ, USA.
  3. Medical Associates Research Group, San Diego, CA, USA.
  4. Atlanta Gastroenterology Associates, Atlanta, GA, USA.
  5. The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA.
  6. Research and Education Inc, San Diego, CA, USA.
  7. CRI Lifetree, Salt Lake City, UT, USA.
  8. Inova Fairfax Hospital, Center for Liver Diseases, Falls Church, VA, USA.
  9. Miami Research Associates, South Miami, FL, USA.
  10. Mercy Medical Center, Baltimore, MD, USA.
  11. Bristol-Myers Squibb, Princeton, NJ, USA.
  12. Bristol-Myers Squibb, Wallingford, CT, USA.

PMID: 25559328 DOI: 10.1016/j.jhep.2014.12.025

[No abstract available.]

Substances

MeSH terms

Publication Types